We Care. We are Complement.

At Apellis, our commitment to developing transformative complement therapies extends beyond discovery and development to fully encompass our vision of being a compassionate organization known for revolutionary science and contributions to humankind.

Apellis global grants and giving support is varied and includes donations, grants, and sponsorships. Grants and giving support to patient and professional organizations and institutions are considered for programs and activities that:

• Provide broad public benefit, improve patient experiences and outcomes, and advance scientific knowledge
• Are aligned with Apellis’ scientific and medical areas of interest
• Correspond to Apellis’ corporate vision and values
• Are consistent with Apellis’ business, public policy, or philanthropy priorities

At Apellis, we strive to ensure our interactions with independent organizations and the provision of financial support are in strict compliance with relevant laws and regulations, industry codes and guidelines, and Apellis policy. Regardless of the type of support, all organizations that apply for corporate giving must review and adhere to Apellis grants and giving requirements.

Apellis is accepting funding requests for Medical Education Grants, Corporate Funding (Patient Advocacy, Sponsorships or Donations) for programs and activities in January, February and March (Q1) of 2025 for evaluation by end of 2024.

Evaluation of new funding requests for programs or activities occurring in April-June (Q2) of 2025 will be evaluated by end of  January 2025.

To learn more about Apellis grants and giving and to apply for support, click on the buttons below.